Interactive Session:
184. Case-Based Hot Topics for the Mycology Consultant
Sunday, October 23, 2011: 7:30 AM-9:00 AM
Room: Grand Ballroom (East-West)

Learning Objectives:

Upon completion of this session, participants will improve their ability to:

  • employ newer diagnostic strategies for invasive fungal disease
  • select appropriate therapy for fungal diseases
  • identify antifungal resistance
  • manage appropriate dosing and toxicity in selected populations

Target Audience: Researchers, Pharmacists, Nurses, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, HIV Clinicians, Health Care Workers, Fellows-in-Training, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Interactive Moderators:  John Baddley, MD, MSPH, University of Alabama at Birmingham and George R. Thompson III, MD, University of California-Davis

Presentations:

7:30 AM
Interactive Panelist
Richard Hamill, MD, FIDSA

7:31 AM
Interactive Panelist
Michele Morris, MD, FIDSA

7:32 AM
Interactive Panelist
Thomas Patterson, MD, FIDSA

7:33 AM
Interactive Panelist
Shmuel Shoham, MD

7:34 AM
Interactive Panelist
Susan Hadley, MD, FIDSA

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 application-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-154-L01-P

Disclosures:

J. Baddley, Pfizer: Consultant and Grant Investigator, Consulting fee
Merck: Scientific Advisor, Consulting fee

G. R. Thompson III, Pfizer: Investigator, Research support

R. Hamill, None

M. Morris, Astellas: Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Research support and Speaker honorarium
Basilea: Investigator, Research support
Merck: Scientific Advisor, Consulting fee
Pfizer: Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Research support and Speaker honorarium

T. Patterson, Astellas: Grant Investigator, Research grant
Basilea: Consultant, Grant Investigator and Scientific Advisor, Consulting fee and Research grant
Merck: Grant Investigator and Scientific Advisor, Consulting fee and Research grant
Pfizer: Consultant, Grant Investigator and Scientific Advisor, Consulting fee and Research grant
Schering-Plough: Grant Investigator, Research grant
Toyoma: Consultant, Consulting fee

S. Shoham, pfizer: Grant Investigator, Investigator and Speaker's Bureau, Research grant, Research support and Speaker honorarium
astellas: Grant Investigator, Investigator and Speaker's Bureau, Research grant, Research support and Speaker honorarium
merck: Consultant, Grant Investigator and Investigator, Consulting fee, Research grant and Research support
schering plough: Speaker's Bureau, Speaker honorarium
advandx: Consultant, Investigator and Speaker's Bureau, Research grant, Research support and Speaker honorarium
bio-merieux: Speaker's Bureau, Speaker honorarium
cylex: Consultant, Consulting fee

S. Hadley, Merck & Co.: Data Safety Monitoring Board, Consulting fee

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.